Moderna Inc CEO Stephane Bancel discusses the 'business cost structure' of the industry following the vaccine maker's gloomier-than-expected outlook. He speaks with Bloomberg's Guy Johnson and Alix Steel.
See omnystudio.com/listener for privacy information.